Abstracts tagged "Rheumatoid arthritis (RA)"

Abstract Number: 413 • 2012 ACR/ARHP Annual Meeting
α(1,2)-Linked Fucosylated Cytokines Are Upregulated in Rheumatoid Arthritis
Takeo Isozaki¹, Jeffrey H. Ruth², M. Asif Amin¹, Phillip L. Campbell¹, Christine M. Ha² and Alisa E. Koch³, ¹Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, ²Internal Medicine, Division of Rheumatology, University of Michigan Medical Center, Ann Arbor, MI, ³Internal Medicine - Rheumatology, University of Michigan Medical School, Ann Arbor, MI
Background/Purpose: Glycosylation is a common post-translational modification of proteins in eukaryotes. Fucosylated glycans are synthesized by fucosyltransferases (futs). We previously reported that sialyl Lewisx, synthesized…
Abstract Number: 89 • 2012 ACR/ARHP Annual Meeting
Poor to Moderate Performance of Patient Self-Report in Indentifying Periodontitis in Patients with Rheumatoid Arthritis
Ted R. Mikuls¹, Jeffrey Payne², Harlan Sayles³, Shawneen Gonzalez², Jeffrey Markt⁴, Mark Beatty², Grant W. Cannon⁵, David McGowan⁶, Gail S. Kerr⁷, Robert Redman⁸, Andreas M. Reimold⁹ and Garth Griffiths¹⁰, ¹Omaha VA Medical Center and University of Nebraska Medical Center, Omaha, NE, ²College of Dentistry, University of Nebraska Medical Center, Lincoln, NE, ³College of Public Health, University of Nebraska Medical Center, Omaha, NE, ⁴Otol-Head and Neck Surgery, University of Nebraska Medical Center, Omaha, NE, ⁵Division of Rheumatology, George E. Wahlen VA Medical Center, Salt Lake City, UT, ⁶Dentistry, George E. Wahlen VA Medical Center, Salt Lake City, UT, ⁷Rheumatology, Washington DC VAMC, Georgetown and Howard University, Washington, DC, ⁸Dentistry, Washington DC VA, Georgetown and Howard University, Washington, DC, ⁹Rheumatology, Dallas VA and University of Texas Southwestern, Dallas, TX, ¹⁰Dentistry, Dallas VA and University of Texas Southwestern, Dallas, TX
Background/Purpose: Periodontitis (PD) is a putative risk factor for rheumatoid arthritis (RA) risk and progression. PD is defined as inflammation of the supporting tissues of the teeth, progressive attachment and…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].